JHL Biotech hosts Brazilian delegation in Taiwan to advance biosimilar collaborations
JHL Biotech, an emerging biosimilars company in Taiwan, hosted a delegation of Brazilian government officials and top-ranking biotech executives who visited the company's headquarters in support of Brazil's partnership with JHL to produce affordable, world-class biosimilars.
The delegation included Antonio Werneck, president of In Vitro Brazil, Augusto Raupp, president of the Research Foundation of the State of Rio de Janeiro (FAPERJ), Joao Transmontano, chief executive of Biolotus Biotech, and Tande Vieira, Undersecretary of State of Science, Technology, and Innovation and coordinator of the executive group of Life Sciences of the Industrial Complex of Rio de Janeiro.
Attraction of Brazil for biosimilars
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Biosimilars
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze